Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis - Reply
Bt. Sadatipour et al., Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis - Reply, ANN NEUROL, 47(5), 2000, pp. 685-685